| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.0M | — | -66.6% |
| R&D Expense | $7.6M | -12.2% | -53.3% |
| SG&A Expense | $4.1M | -5.8% | -11.0% |
| Operating Income | -$10.7M | +17.8% | +40.2% |
| Net Income | -$10.1M | +19.3% | +39.7% |
| EPS (Basic) | -$0.14 | +41.7% | +57.6% |
| EPS (Diluted) | -$0.14 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $42.5M | -15.7% | -2.9% |
| Current Assets | $90.7M | +65.9% | -8.1% |
| Total Assets | $100.3M | +55.9% | -10.2% |
| Current Liabilities | $5.3M | +0.0% | -57.0% |
| Total Liabilities | $7.1M | -3.5% | -53.2% |
| Stockholders' Equity |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$31.4M | — | — |
| Capital Expenditures | $71K | — | — |
| Investing Cash Flow | -$27.9M | — | — |
| Financing Cash Flow | $44.4M | — | — |
| Free Cash Flow | -$31.5M | — | — |
| +57.6% |
| $93.2M |
| +63.5% |
| -3.5% |